EP3773589
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.4.2019:
1.11.2023:
19718531.7
:
2.4.2039
:
RET INHIBITOR FOR USE IN TREATING CANCER HAVING A RET ALTERATION
3.4.2019
1.11.2023
:
Blueprint Medicines Corporation:
45 Sidney Street, Cambridge, MA 02139, US
:
EVANS RAAB, Erica:
Cambridge, Massachusetts 02139, US
:
WOLF, Beni B.:
Cambridge, Massachusetts 02139, US
:
201862652284 P:
3.4.2018:
US
:
201862656297 P:
11.4.2018:
US
:
201862657605 P:
13.4.2018:
US
:
201862741683 P:
5.10.2018:
US
:
US2019025655:
3.4.2019
:
A61K 31/506, A61K 45/06, A61P 35/04, A61P 35/00